Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dutasteride intradermal injection response in female pattern hair loss with versus without metabolic syndrome
PACTR201806003307977Recruiting
- Sponsor
- Al-Azhar University
- Start
- Apr 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dutasteride in Female Pattern Hair Loss (FPHL) (2 arms), sponsored by Al-Azhar University. Started Apr 2018; status: recruiting.
02
Drugs
dutasteride
03
Conditions
Female Pattern Hair Loss (FPHL)
Beyond the preview
Go deeper on PACTR201806003307977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201806003307977.